Diphtheria Antitoxin Production and Procurement Practices and Challenges
Emerging Infectious Diseases · 2025-12 · 31 (12)
DOI: 10.3201/eid3112.250796 ↗Kurz gefasst
Fachartikel in der Zeitschrift Emerging Infectious Diseases, 2025-12. Verfasst von Caroline Marshall und 7 weiteren Autor:innen. Hauptthemen laut MEDLINE: Diphtheria Antitoxin, Diphtheria, Antibodies, Monoclonal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Treatment of respiratory diphtheria requires prompt administration of equine diphtheria antitoxin (DAT) to neutralize circulating toxin. We conducted surveys of key procurement agencies and manufacturers currently engaged in DAT manufacturing or procurement, along with key informant interviews with developers of monoclonal antibodies. Our findings indicate that prices and availability of DAT vary and that prediction of demand is challenging for both manufacturers and procurement agencies. Substantial concerns were raised over the inability to obtain enough DAT to respond to increasing global outbreaks. Monoclonal antibody developers noted financial challenges in advancing their clinical and manufacturing progress.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Zitieren
APA
Marshall, C., Caro, W. P., Costa, A., Ho, L. L., Gardner, P. J., Guitton, C., Potet, J., & Sparrow, E. (2025). Diphtheria Antitoxin Production and Procurement Practices and Challenges. Emerging Infectious Diseases, 31(12). https://doi.org/10.3201/eid3112.250796
Vancouver
Marshall C, Caro WP, Costa A, Ho LL, Gardner PJ, Guitton C, et al. Diphtheria Antitoxin Production and Procurement Practices and Challenges. Emerging Infectious Diseases. 2025;31(12). doi:10.3201/eid3112.250796
BibTeX
@article{Marshall2025,
author = {Marshall, Caroline and Caro, William Perea and Costa, Alejandro and Ho, Lee Lee and Gardner, Peter J and Guitton, Christophe and Potet, Julien and Sparrow, Erin},
title = {Diphtheria Antitoxin Production and Procurement Practices and Challenges},
journal = {Emerging Infectious Diseases},
year = {2025},
volume = {31},
number = {12},
doi = {10.3201/eid3112.250796}
}
EUVIMED